🏥 治験ポータル
← 治験一覧に戻る

単一ステントおよびKISSingバルーン試験による分岐部病変の治療

基本情報

NCT ID
NCT00798954
ステータス
完了
試験のフェーズ
第4相
試験タイプ
介入
目標被験者数
800
治験依頼者名
Vulnerable Plaque Society

概要

The use of DES have not diminished the need of improved treatment strategies , especially the treatment of bifurcation lesions still leave much to be clarified. Particularly, for bifurcation lesions where stenting the main branch could result in an obstruction of a vital side branch, many reports have been about using 2 drug-eluting stents. Resulting in less than favorable, target lesion revascularization (TLR) rates, with 10-15% for main branch and 11-40% for side branch. In Japan, the PERFECT multi-center registry evaluated outcomes of single stenting plus kissing balloon technique after Directional Coronary Atherectomy (DCA) removal of tissue plaques. TLR rates for both main branch and side branch were a satisfactory 1.3%. However, the DCA technique is mainly suitable for proximal coronary artery lesions, and takes skilled operators. For the treatment of relatively distal bifurcation lesions, where first POBA is performed, then the lesion is stented, followed by kissing balloon technique to fully expand the side branch, is considered a viable treatment. The Toyohashi Heart Center outcomes from August 2004 for this single stent and kissing ballooning technique, using the sirolimus-eluting stent on bifurcation lesions, achieved a satisfactory 5.2% TLR for both main and side branches, suggesting that using two stents may not be necessarily the ideal treatment. The paclitaxel-eluting stent is expected to become available in Japan from June 2007. This stent's cells can be expanded to a maximum of 3.5mm, which should provide a larger lumen access for side-branch treatment. As such, we developed this study to compare the outcomes of paclitaxel-eluting and sirolimus-eluting stents in bifurcation lesions that require side branch dilatation using the kissing ballooning technique.

対象疾患

Ischemic Heart DiseaseRestenosis

介入

Sirolimus-eluting coronary stent (Cypher)(DEVICE)
Paclitaxel-eluting stent (TAXUS)(DEVICE)

依頼者(Sponsor)

実施施設 (17)

一般財団法人 脳神経疾患研究所 附属 総合南東北病院

Kōriyama, Fukushima, Japan

市立千歳市民病院

Chitose, Hokkaido, Japan

帝京大学ちば総合医療センター

Ichihara, Chiba, Japan

医療法人徳洲会松原徳洲会病院

Matsubara, Osaka, Japan

Cardiovascular Institute Hospital

Minatoku, Tokyou, Japan

一般財団法人自警会 東京警察病院

Chiyoda City, Tokyo, Japan

群馬県立心臓血管センター

Maebashi, Gunma, Japan

りんくう総合医療センター

Izumisano, Osaka, Japan

東京医科大学病院

Shinjuku, Tokyo, Japan

Vulnerable Plaque Society

Toyohashi, Aichi-ken, Japan

三田市民病院

Sanda, Hyōgo, Japan

Kihara Junkanki Hospital

Asahikawa, Hokkaido, Japan

Shinko Kagogwa Hospital

Kakogawa, Hyōgo, Japan

北海道大学病院

Sapporo, Hokkaido, Japan

医療法人澄心会 豊橋ハートセンター

Toyohashi, Aichi-ken, Japan

医療法人社団明芳会 板橋中央総合病院

tabashi City, Tokyo, Japan

医療法人社団 東大和循環器科内科

Toyohashi, Aichi-ken, Japan